This topic contains a solution. Click here to go to the answer

Author Question: In a chi-squared test of a contingency table, the value of the test statistic was 2 = 15.652, and ... (Read 155 times)

ec501234

  • Hero Member
  • *****
  • Posts: 573
In a chi-squared test of a contingency table, the value of the test statistic was 2 = 15.652, and the critical value at  = .025 was 11.1433 . Thus, we must reject the null hypothesis at  = .025.
  Indicate whether the statement is true or false

Question 2

The minimum expected opportunity loss is also equal to the:
 a. expected profit under certainty.
  b. expected value of perfect information.
  c. coefficient of variation.
  d. expected value under certainty minus the expected monetary value of the worst alternative.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emily12345

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

T

Answer to Question 2

B




ec501234

  • Member
  • Posts: 573
Reply 2 on: Jun 24, 2018
YES! Correct, THANKS for helping me on my review


xthemafja

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library